1. Home
  2. CERT vs BAK Comparison

CERT vs BAK Comparison

Compare CERT & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERT
  • BAK
  • Stock Information
  • Founded
  • CERT 2008
  • BAK 1972
  • Country
  • CERT United States
  • BAK Brazil
  • Employees
  • CERT N/A
  • BAK N/A
  • Industry
  • CERT Retail: Computer Software & Peripheral Equipment
  • BAK Major Chemicals
  • Sector
  • CERT Technology
  • BAK Industrials
  • Exchange
  • CERT Nasdaq
  • BAK Nasdaq
  • Market Cap
  • CERT 2.3B
  • BAK 1.8B
  • IPO Year
  • CERT 2020
  • BAK N/A
  • Fundamental
  • Price
  • CERT $13.17
  • BAK $4.42
  • Analyst Decision
  • CERT Buy
  • BAK Strong Buy
  • Analyst Count
  • CERT 7
  • BAK 3
  • Target Price
  • CERT $15.92
  • BAK $9.75
  • AVG Volume (30 Days)
  • CERT 1.4M
  • BAK 747.8K
  • Earning Date
  • CERT 02-26-2025
  • BAK 03-18-2025
  • Dividend Yield
  • CERT N/A
  • BAK N/A
  • EPS Growth
  • CERT N/A
  • BAK N/A
  • EPS
  • CERT N/A
  • BAK N/A
  • Revenue
  • CERT $372,797,000.00
  • BAK $13,764,416,401.00
  • Revenue This Year
  • CERT $10.48
  • BAK $15.77
  • Revenue Next Year
  • CERT $9.94
  • BAK $9.88
  • P/E Ratio
  • CERT N/A
  • BAK N/A
  • Revenue Growth
  • CERT 5.62
  • BAK 2.86
  • 52 Week Low
  • CERT $9.41
  • BAK $3.69
  • 52 Week High
  • CERT $19.87
  • BAK $10.98
  • Technical
  • Relative Strength Index (RSI)
  • CERT 48.29
  • BAK 46.67
  • Support Level
  • CERT $13.54
  • BAK $4.19
  • Resistance Level
  • CERT $15.69
  • BAK $4.74
  • Average True Range (ATR)
  • CERT 0.70
  • BAK 0.19
  • MACD
  • CERT -0.16
  • BAK -0.02
  • Stochastic Oscillator
  • CERT 2.70
  • BAK 35.94

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

About BAK Braskem SA ADR

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

Share on Social Networks: